The Ensign Group IN ENSG

$171.78 +2.15 (1.27%)

Valuation

Market cap
10,011,682,000
Revenue TTM
$5,057,840,000
Net income TTM
$343,970,000
PE ratio
26.22
Forward PE
24.11
Profit margin
6.80%
Debt to equity
0.06

Trading

Volume
356,100
Avg volume
358,478
Day's range
$169.64 – $173.14
Shares out
58,282,000
Stochastic %K
34%
Beta
0.66
Analysts
Strong Sell
Price target
$213.50

Price

Company profile

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and sta...

Show more

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
949 487 9500
Website
https://ensigngroup.net
Address
29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, United States

Latest news

No headlines yet.

Stocktwits

Estimize Aug 4, 8:00 PM
Wall St is expecting 1.96 EPS for $ENSG Q3 [Reporting 11/02 AMC] http://www.estimize.com/intro/ensg?chart=historical&metric_name=eps&utm_co
0 replies
Maxwell_Osgood Jul 28, 11:17 PM
$ENSG Makin the money...
0 replies
d_risk Jul 27, 11:53 PM
$ENSG - The Ensign Group Inc - 10Q - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +123.6% above peer average (26,214 vs 11,726 across 655 peers). Ensign flags heightened risk from post-2025 Medicaid integrity push, new CMS work-requirement rules, and proposed limits on Medicaid state-directed payments, plus tariff-driven cost and supply chain shocks and AI-boosted cyber and liability risks, while trimming several prior business and capital-structure risk disclosures. #HealthcareServices #MedicaidPolicy #RegulatoryRisk #SupplyChainDisruptions #CybersecurityRisk 🟢 Added 🟠 Removed https://d-risk.ai/ENSG/10-Q/2026-07-27
0 replies
DonCorleone77 Jul 27, 1:12 PM
$ENSG $BKR $AZN $FBRX $GOSS PRE-MARKET MOVERS: Currently Higher After Earnings: - Ensign Group (ENSG) up 11.0% - Baker Hughes (BKR) up 3.8% - AstraZeneca (AZN) up 1.2% - Alliance Resource Partners (ARLP) up 0.4% Currently Also Higher: - Forte Biosciences (FBRX) up 39.5% after entering into a definitive agreement under which Argenx (ARGX) will acquire the company for $77 per share in cash - Gossamer Bio (GOSS) up 26.4% after proceeding toward a planned NDA submission for seralutinib for the treatment of patients with PAH in September and reacquiring worldwide development and commercial rights to seralutinib from Chiesi - D-Wave Quantum (QBTS) up 8.5% after AT&T (T) announced an agreement to expand its use of D-Wave's quantum computing technology and plans to use the technology to address complex optimization challenges across its network operations Currently Lower After Earnings: - Alpha Metallurgical (AMR) down 3.9% Currently Also Lower: - MapLight Therapeutics (MPLT) down 62.9% after reporting topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA, an oral M1/M4 muscarinic agonist co-formulated with a peripherally acting anticholinergic, in adults with an acute exacerbation of schizophrenia - Argenx (ARGX) down 0.7% after entering into an agreement to acquire Forte Biosciences for $77 per share in cash
0 replies
katiemcdaniels96 Jul 27, 11:15 AM
$ENSG The Ensign Group, Inc. - The Ensign Group Reports Second Quarter 2026 Results https://share.google/T74Ybv1Q9zOY0XuRB
0 replies
StocktwitsEarnings Jul 27, 10:10 AM
$ENSG Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.72 up 16.22% YoY • Reported revenue of $1.44B up 17.33% YoY • The Ensign Group is increasing its annual 2026 earnings guidance to $7.75 to $7.85 per diluted share and raising annual revenue guidance to $5.87 billion to $5.92 billion for the year.
0 replies
Maxwell_Osgood Jun 24, 2:12 AM 0 replies
Estimize Jun 22, 12:03 PM
Wall St is expecting 1.85 EPS for $ENSG Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/ensg?chart=historical&metric_name=eps&utm_co
0 replies